IRIS Accounts Production v23.3.0.418 04840826 Board of Directors Board of Directors 28.11.21 28.2.23 28.2.23 false true false false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure048408262021-11-27048408262023-02-28048408262021-11-282023-02-28048408262020-11-28048408262020-11-292021-11-27048408262021-11-2704840826ns16:EnglandWales2021-11-282023-02-2804840826ns15:PoundSterling2021-11-282023-02-2804840826ns11:Director12021-11-282023-02-2804840826ns11:Director22021-11-282023-02-2804840826ns11:PrivateLimitedCompanyLtd2021-11-282023-02-2804840826ns11:SmallEntities2021-11-282023-02-2804840826ns11:AuditExempt-NoAccountantsReport2021-11-282023-02-2804840826ns11:SmallCompaniesRegimeForDirectorsReport2021-11-282023-02-2804840826ns11:SmallCompaniesRegimeForAccounts2021-11-282023-02-2804840826ns11:FullAccounts2021-11-282023-02-280484082612021-11-282023-02-2804840826ns11:RegisteredOffice2021-11-282023-02-2804840826ns6:CurrentFinancialInstruments2023-02-2804840826ns6:CurrentFinancialInstruments2021-11-2704840826ns6:Non-currentFinancialInstruments2023-02-2804840826ns6:Non-currentFinancialInstruments2021-11-2704840826ns6:ShareCapital2023-02-2804840826ns6:ShareCapital2021-11-2704840826ns6:RetainedEarningsAccumulatedLosses2023-02-2804840826ns6:RetainedEarningsAccumulatedLosses2021-11-2704840826ns6:NetGoodwill2021-11-282023-02-2804840826ns6:IntangibleAssetsOtherThanGoodwill2021-11-282023-02-2804840826ns6:PlantMachinery2021-11-282023-02-2804840826ns6:NetGoodwill2021-11-2704840826ns6:NetGoodwill2023-02-2804840826ns6:NetGoodwill2021-11-2704840826ns6:LandBuildings2021-11-2704840826ns6:PlantMachinery2021-11-2704840826ns6:LandBuildings2021-11-282023-02-2804840826ns6:LandBuildings2023-02-2804840826ns6:PlantMachinery2023-02-2804840826ns6:LandBuildings2021-11-2704840826ns6:PlantMachinery2021-11-2704840826ns6:WithinOneYearns6:CurrentFinancialInstruments2023-02-2804840826ns6:WithinOneYearns6:CurrentFinancialInstruments2021-11-27
















Lallian Pharmacy Limited

Unaudited Financial Statements

for the Period 28 November 2021 to 28 February 2023






Lallian Pharmacy Limited (Registered number: 04840826)






Contents of the Financial Statements
for the Period 28 November 2021 to 28 February 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Lallian Pharmacy Limited

Company Information
for the Period 28 November 2021 to 28 February 2023







DIRECTORS: J S Kang
Mrs E C Kang





REGISTERED OFFICE: 2076 Lynstock House
Lynstock Way
Bolton
BL6 4SA





REGISTERED NUMBER: 04840826 (England and Wales)





ACCOUNTANTS: Matthews Sutton & Co Ltd
Chartered Certified Accountants
48 - 52 Penny Lane
Mossley Hill
Liverpool
Merseyside
L18 1DG

Lallian Pharmacy Limited (Registered number: 04840826)

Balance Sheet
28 February 2023

2023 2021
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - 37,114
Tangible assets 5 - 172,972
Investment property 6 - 45,000
- 255,086

CURRENT ASSETS
Stocks 20,566 115,040
Debtors 7 111,021 210,627
Cash at bank and in hand 24,002 199,267
155,589 524,934
CREDITORS
Amounts falling due within one year 8 163,193 475,091
NET CURRENT (LIABILITIES)/ASSETS (7,604 ) 49,843
TOTAL ASSETS LESS CURRENT
LIABILITIES

(7,604

)

304,929

CREDITORS
Amounts falling due after more than one
year

9

-

289,624
NET (LIABILITIES)/ASSETS (7,604 ) 15,305

CAPITAL AND RESERVES
Called up share capital 4 4
Retained earnings (7,608 ) 15,301
SHAREHOLDERS' FUNDS (7,604 ) 15,305

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 28 February 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 28 February 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Lallian Pharmacy Limited (Registered number: 04840826)

Balance Sheet - continued
28 February 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 November 2023 and were signed on its behalf by:




J S Kang - Director



Mrs E C Kang - Director


Lallian Pharmacy Limited (Registered number: 04840826)

Notes to the Financial Statements
for the Period 28 November 2021 to 28 February 2023

1. STATUTORY INFORMATION

Lallian Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2004, has been restated and is now being amortised over five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 15% on reducing balance

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 12 (2021 - 15 ) .

Lallian Pharmacy Limited (Registered number: 04840826)

Notes to the Financial Statements - continued
for the Period 28 November 2021 to 28 February 2023

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 28 November 2021
and 28 February 2023 265,100
AMORTISATION
At 28 November 2021 227,986
Charge for period 37,114
At 28 February 2023 265,100
NET BOOK VALUE
At 28 February 2023 -
At 27 November 2021 37,114

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 28 November 2021 161,903 43,457 205,360
Disposals (161,903 ) (43,457 ) (205,360 )
At 28 February 2023 - - -
DEPRECIATION
At 28 November 2021 - 32,388 32,388
Eliminated on disposal - (32,388 ) (32,388 )
At 28 February 2023 - - -
NET BOOK VALUE
At 28 February 2023 - - -
At 27 November 2021 161,903 11,069 172,972

6. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 28 November 2021 45,000
Disposals (45,000 )
At 28 February 2023 -
NET BOOK VALUE
At 28 February 2023 -
At 27 November 2021 45,000

Lallian Pharmacy Limited (Registered number: 04840826)

Notes to the Financial Statements - continued
for the Period 28 November 2021 to 28 February 2023

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2021
£    £   
Trade debtors 84,919 52,947
Other debtors 26,102 157,680
111,021 210,627

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2021
£    £   
Bank loans and overdrafts - 33,929
Trade creditors 143,390 370,322
Taxation and social security 8,420 37,182
Other creditors 11,383 33,658
163,193 475,091

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2021
£    £   
Bank loans - 289,624

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal - 123,869

10. ULTIMATE CONTROLLING PARTY

By virtue of the share ownership split of the company, it is the opinion of the directors that there is no ultimate controlling party.